1. Home
  2. SSKN vs ERNA Comparison

SSKN vs ERNA Comparison

Compare SSKN & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSKN
  • ERNA
  • Stock Information
  • Founded
  • SSKN 1989
  • ERNA 2018
  • Country
  • SSKN United States
  • ERNA United States
  • Employees
  • SSKN N/A
  • ERNA N/A
  • Industry
  • SSKN Medical/Dental Instruments
  • ERNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSKN Health Care
  • ERNA Health Care
  • Exchange
  • SSKN Nasdaq
  • ERNA Nasdaq
  • Market Cap
  • SSKN 12.1M
  • ERNA 14.2M
  • IPO Year
  • SSKN 2005
  • ERNA N/A
  • Fundamental
  • Price
  • SSKN $2.40
  • ERNA $0.18
  • Analyst Decision
  • SSKN Strong Buy
  • ERNA
  • Analyst Count
  • SSKN 1
  • ERNA 0
  • Target Price
  • SSKN $6.00
  • ERNA N/A
  • AVG Volume (30 Days)
  • SSKN 14.3K
  • ERNA 453.6K
  • Earning Date
  • SSKN 05-14-2025
  • ERNA 06-13-2025
  • Dividend Yield
  • SSKN N/A
  • ERNA N/A
  • EPS Growth
  • SSKN N/A
  • ERNA N/A
  • EPS
  • SSKN N/A
  • ERNA N/A
  • Revenue
  • SSKN $33,620,000.00
  • ERNA $535,000.00
  • Revenue This Year
  • SSKN $3.31
  • ERNA N/A
  • Revenue Next Year
  • SSKN $9.67
  • ERNA N/A
  • P/E Ratio
  • SSKN N/A
  • ERNA N/A
  • Revenue Growth
  • SSKN 3.30
  • ERNA 365.22
  • 52 Week Low
  • SSKN $2.10
  • ERNA $0.15
  • 52 Week High
  • SSKN $4.10
  • ERNA $2.63
  • Technical
  • Relative Strength Index (RSI)
  • SSKN 50.58
  • ERNA 32.65
  • Support Level
  • SSKN $2.29
  • ERNA $0.17
  • Resistance Level
  • SSKN $2.62
  • ERNA $0.25
  • Average True Range (ATR)
  • SSKN 0.23
  • ERNA 0.02
  • MACD
  • SSKN -0.01
  • ERNA -0.01
  • Stochastic Oscillator
  • SSKN 39.71
  • ERNA 11.44

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

Share on Social Networks: